Methods of renal replacement therapy in intensive care unit
Abstract
This article presents the history of the development of renal replacement therapy (RRT) in patients intensively treated for acute kidney injury (AKI). The basic problem is the significant, high morbidity and, unfortunately, still high mortality due to AKI in patients in intensive care units (ICU). The incidence of AKI in the ICU has been estimated to range from 5% to 50%. Currently, treatment options for RRT include intermittent, prolonged, and continuous therapies. In this article, we focused particular attention on continuous renal replacement therapy (CRRT). The subject of the discussion are the basic dialysis techniques: hemodialysis, hemofiltration, hemodiafiltration, ultrafiltration and peritoneal dialysis. Currently, continuous therapies are preferred in hemodynamically unstable patients requiring vasoactive drugs. However, especially during the COVID-19 pandemic, extended therapy has gained importance, mainly due to the huge increase in the number of patients requiring RRT. In hemodynamically stable patients requiring RRT, intermittent hemodialysis still has its place. An intensive care physician involved in life-saving interventions and treatment of AKI most often uses continuous methods. Cooperation with nephrologists is particularly important in the treatment of a patient with AKI and may contribute to the optimal use of various RRT techniques. The primary goal of this article is to present the process of initiating and conducting RRT in the ICU to a wider group of physicians. Moreover, based on the latest reports, the individual, most frequently used dialysis techniques in the ICU are described.
Keywords: renal replacement therapy intensive care
References
- Haas G. Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse. Klinische Wochenschrift. 1925; 4(1): 13–14.
- KOLFF WJ. Dialysis in treatment of uremia: artificial kidney and peritoneal lavage. AMA Arch Intern Med. 1954; 94(1): 142–160.
- Kramer P, Wigger W, Rieger J, et al. [Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics]. Klin Wochenschr. 1977; 55(22): 1121–1122.
- Kumar VA, Craig M, Depner TA, et al. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis. 2000; 36(2): 294–300.
- Overberger P, Pesacreta M, Palevsky PM, et al. VA/NIH Acute Renal Failure Trial Network. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol. 2007; 2(4): 623–630.
- Chawla LS, Bellomo R, Bihorac A, et al. Acute Disease Quality Initiative Workgroup 16.. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017; 13(4): 241–257.
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4): c179–c184.
- Gaudry S, Hajage D, Schortgen F, et al. AKIKI Study Group. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med. 2016; 375(2): 122–133.
- Bell M, Granath F, Schön S, et al. SWING. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med. 2007; 33(5): 773–780.
- Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007(3): CD003773.
- Barbar SD, Clere-Jehl R, Bourredjem A, et al. IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med. 2018; 379(15): 1431–1442.
- Bagshaw SM, Wald R, Adhikari NKJ, et al. STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, United Kingdom Critical Care Research Group, Canadian Nephrology Trials Network, Irish Critical Care Trials Group. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020; 383(3): 240–251.
- Bellomo R, Baldwin I, Fealy N. Prolonged Intermittent Renal Replacement Therapy in the Intensive Care Unit. Critical Care and Resuscitation. 2002; 4(4): 281–290.
- Levine Z, Vijayan A. Prolonged Intermittent Kidney Replacement Therapy. Clin J Am Soc Nephrol. 2023; 18(3): 383–391.
- Sethi S, Mangat G, Soundararajan A, et al. Archetypal sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring kidney replacement therapy: towards an adequate therapy. J Nephrol. 2023; 36(7): 1789–1804.
- Ricci Z, Ronco C. Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis. Crit Care Med. 2008; 36(4 Suppl): S229–S237.
- Bowry SK, Kircelli F, Misra M. Flummoxed by flux: the indeterminate principles of haemodialysis. Clin Kidney J. 2021; 14(Suppl 4): i32–i44.
- Chen LX, Demirjian S, Udani SM, et al. Cytokine Clearances in Critically Ill Patients on Continuous Renal Replacement Therapy. Blood Purif. 2018; 46(4): 315–322.
- Troyanov S, Cardinal J, Geadah D, et al. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant. 2003; 18(5): 961–966.
- van Gelder MK, Middel IR, Vernooij RWM, et al. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome. Toxins (Basel). 2020; 12(4).
- Kitchlu A, Adhikari N, Burns KEA, et al. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. BMC Nephrol. 2015; 16: 127.
- Palmer R. As it was in the Beginning: A History of Peritoneal Dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 1981; 2(1): 16–22.
- Uchino S, Doig GS, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Diuretics and mortality in acute renal failure. Crit Care Med. 2004; 32(8): 1669–1677.
- Cullis B, Al-Hwiesh A, Kilonzo K, et al. ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults). Perit Dial Int. 2021; 41(1): 15–31.
- Patarroyo M, Wehbe E, Hanna M, et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol. 2012; 60(19): 1906–1912.
- Tandukar S, Palevsky P. Continuous Renal Replacement Therapy. Chest. 2019; 155(3): 626–638.
- Vinsonneau C, Camus C, Combes A, et al. Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006; 368(9533): 379–385.
- Oeyen SG, Benoit DD, Annemans L, et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med. 2013; 39(5): 889–898.
- Uchino S, Bellomo R, Kellum JA, et al. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Writing Committee. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs. 2007; 30(4): 281–292.
- Liu SY, Xu SY, Yin Lu, et al. Emergency Medical Doctor Branch of the Chinese Medical Doctor Association. Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus. Mil Med Res. 2023; 10(1): 23.
- Luppa PB, Müller C, Schlichtiger A, et al. Point-of-care testing (POCT): Current techniques and future perspectives. Trends Analyt Chem. 2011; 30(6): 887–898.
- Bellomo R, Baldwin I, Ronco C, et al. ICU-Based Renal Replacement Therapy. Crit Care Med. 2021; 49(3): 406–418.
- Bottari G, Ranieri VM, Ince C, et al. Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives. Crit Care. 2024; 28(1): 432.
- Leaf DE, Waikar SS. IDEAL-ICU in Context. Clin J Am Soc Nephrol. 2019; 14(8): 1264–1267.
- Sanderson KR, Harshman LA. Renal replacement therapies for infants and children in the ICU. Curr Opin Pediatr. 2020; 32(3): 360–366.
- Lai TS, Shiao CC, Wang JJ, et al. Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2017; 7(1): 38.
- Bagshaw SM, Wald R. Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury. Kidney Int. 2017; 91(5): 1022–1032.
- Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020; 10(1): 32.
- Wald R, Beaubien-Souligny W, Chanchlani R, et al. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022; 48(10): 1368–1381.
